NADMED

Helsinki, Finland

Nadmed brings to market a new type of NAD metabolite measurement technology.

$3.9M raised

Aug 2024

Series A

Top Investors

Nordic Science InvestmentsVoima VenturesBusiness FinlandUniversity of HelsinkiCVX Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NADMED raised?

NADMED has raised $3.9M in total funding. The most recent round was Series A. The last funding was announced in August 2024.

Who are NADMED's investors?

NADMED's investors include Nordic Science Investments, Voima Ventures, Business Finland, University of Helsinki, CVX Ventures.

Where is NADMED headquartered?

NADMED is headquartered in Helsinki, Finland.

What does NADMED do?

Nadmed brings to market a new type of NAD metabolite measurement technology.

What stage is NADMED at?

NADMED is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 22, 2024.

MLA

"NADMED — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/nadmed. Accessed June 4, 2026.

APA

VCBacked. (2024). NADMED — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nadmed

Wikipedia (cite web)

{{cite web |title=NADMED — Funding & Investors |url=https://www.vcbacked.co/company/nadmed |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 22, 2024.